13 reports

The US generic drug market reached a value of US$ 83.2 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 105.7 Billion by 2027, exhibiting a CAGR of 3.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Generic Drug
  • United States
  • Chronic Disease Prevalence
  • Generic Drug Sales

The GCC generic drug market reached a value of US$ 4.5 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 9.9 Billion by 2027, exhibiting a CAGR of 14.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Generic Drug
  • GCC
  • Pharmaceutical Production

The global generic drugs market reached a value of US$ 320 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 482.5 Billion by 2027, exhibiting at a CAGR of 7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...

  • Generic Drug
  • World
  • Drug Approval

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D...

  • Research And Development
  • Generic Drug
  • Anti-Infective
  • Parenteral Nutrition
  • In-Store Retail
  • Chronic Disease
  • Pharmacy
  • Cardiology
  • World

The global generic oncology drugs market exhibited strong growth during 2015-2020. Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the...

  • Healthcare
  • Generic Drug
  • Oncology
  • Research And Development
  • Diagnostics
  • Health Services
  • Cancer Diagnostics
  • World

The US generic injectables market reached a value of US$ 16.3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 29.6 Billion by 2027, exhibiting a CAGR of 10.21% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Healthcare
  • In-Store Retail
  • Arthritis
  • Transportation
  • Generic Drug
  • United States
  • Health Expenditure

The global regulatory affairs outsourcing market grew at a CAGR of around 10% during 2015-2020. Looking forward, the analyst expects the market to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Pharmaceutical
  • Generic Drug
  • Clinical Trial
  • Research And Development
  • Public Health
  • Biosimilar
  • World

Canada represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors. The continuous expiration of drug...

  • Generic Drug
  • Canada
  • Health Expenditure
  • Chronic Disease Prevalence

Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of...

  • Generic Drug
  • Brazil
  • Generic Drugs Market Share
  • Generics Use

Japan represents the world’s eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe. Historically, the lower penetration of generic drugs in japan was...

  • Generic Drug
  • Japan
  • Generic Drugs Market Share
  • Drug Approval

A generic drug is a pharmaceutical product that is generally intended to be interchangeable with an innovator or a branded drug. Generics are manufactured without a licence from the innovator company and are identical or bio-equivalent to an innovator drug in dosage form, safety, strength, route of administration, quality,...

  • Generic Drug
  • World
  • Health Expenditure
  • Spending On Medicines

Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result,...

  • Generic Drug
  • World
  • Cancer Incidence

The report entitled “US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook” provides a comprehensive insight into the historical and current trends as well as the future prospects of the US generics market. This study serves as an exceptional tool to understand the sales trends, volume trends, growth, key segments,...

  • Generic Drug
  • United States